HealthGizmodo
A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval
In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.
Join the argument
House rules →Comments load as you scroll.